Clinical Importance of FNDC-5 and Selectin-E mRNA Expression Among Type 2 Diabetics with and without Obesity
Amit K Verma,Alanoud Aladel,Sadaf Dabeer,Irfan Ahmad,Mohammad Idreesh Khan,Malak Ghazi Almutairi,Alhanouf I Al-Harbi,Mirza Masroor Ali Beg,Alhanouf Al-Harbi
DOI: https://doi.org/10.2147/DMSO.S352483
2022-04-02
Abstract:Amit K Verma, 1, 2 Alanoud Aladel, 3 Sadaf Dabeer, 4 Irfan Ahmad, 5 Mohammad Idreesh Khan, 6 Malak Ghazi Almutairi, 7 Alhanouf I Al-Harbi, 8 Mirza Masroor Ali Beg 9, 10 1 Department of Biotechnology, Jamia Millia Islamia University, New Delhi, India; 2 Department of Zoology and Environmental Sciences, Gurukul Kangri Vishwavidyalaya, Haridwar, India; 3 Department of Community Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia; 4 Department of Exercise Science and Sport Management, Kennesaw State University, Kennesaw, GA, USA; 5 Department of Clinical Laboratory Science, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia; 6 Department of Clinical Nutrition, College of Applied Health Sciences in Arras, Qassim University, Buraidah, Saudi Arabia; 7 Department of nutrition, Almethnab General Hospital, Qassim Health Cluster, Ministry of Health, Al Mithnab, Saudi Arabia; 8 Department of Medical Laboratory, College of Applied Medical Sciences, Taibah University, Yanbu, Saudi Arabia; 9 Faculty of Medicine, Ala-Too International University, Bishkek, Kyrgyzstan; 10 Centre for Promotion of Medical Research, Ala-Too International University, Bishkek, Kyrgyzstan Correspondence: Mirza Masroor Ali Beg, Email Background: Type 2 diabetes mellitus (T2DM) is growing illnesses associated with metabolic dysregulation such as obesity affecting a large population become leading causes of death worldwide. Fibronectin type III domain-containing protein 5 (FNDC-5) and selectin-E were suggested to have effects on metabolism and diabetes, therefore present study aimed to evaluate the clinical importance of FNDC-5 and selectin-E among the T2DM patients with and without obesity. Methods: Study included cohort of 200 T2DM patients with and without obesity. We evaluated FNDC-5, selectin-E mRNA expression as well as vitamin-D, and vitamin-B12 levels in among the T2DM patients with and without obesity. Results: Study observed significant difference in biochemical parameters included in study. T2DM patients with obesity had significantly higher fasting blood glucose levels (p< 0.0001) and HbA1c (glycated hemoglobin) (p< 0.0001) compared to those T2DM patients without obesity. T2DM patients with obesity also had higher systolic blood pressure (p=0.001), LDL (low density lipoprotein) (p=0.02), TG (triglycerides) (p=0.02) and cholesterol (p=0.01) compared to T2DM patients without obesity. The mRNA expression of FNDC-5 (p< 0.0001) was lower in T2DM patients with obesity compared to T2DM patients without obesity. It was observed that the T2DM patients with vitamin-D deficiency had significantly lower FNDC-5 mRNA expression (p=0.03) when compared with those with sufficient vitamin-D level. T2DM patients with clinically normal vitamin-B12 level expressed 0.60 fold FNDC-5 mRNA expression while B12 deficient T2DM patients had 0.28 fold FNDC-5 mRNA expression (p=0.005). No as such significant association was was observed with selectin-E. A negative correlation of FNDC-5 mRNA expression with Post prandial glucose (mg/dl) (p=0.04) and TG (mg/dl) (p=0.02) was observed. Conclusion: FNDC-5 down regulation was observed with T2DM with obesity, vitamin-D and vitamin-B12 deficiency suggesting obesity, vitamin-D and vitamin-B12 deficiency could be the factor for FNDC-5 down-regulation leading to worseness or progression of disease. We suggest that FNDC-5 down-regulation could be used as an indicator for T2DM worseness and development of other associated complications. Keywords: type 2 diabetes mellitus, obesity, FNDC-5, selectin-E, mRNA, expression T2DM and associated comorbidity like obesity is an epidemic health problem that has raised concern worldwide. The multifactorial causes of T2DM and obesity lead to health burden among all age groups. Prevention can be achieved by lifestyle and behavioral interventions. However, Because of complex and long-lasting hormonal, metabolic changes, the effectiveness is limited and these adaptations protect against weight loss and promote weight gain. Obesity, excess body weight for height, but this simple definition belies an etiologically complex phenotype primarily associated with excess adiposity, or body fatness. 1 Obesity significantly surges risk of chronic disease morbidity such as disability, depression, type 2 diabetes, cardiovascular disease. 1 FNDC5 encodes irisin hormone has the capacity to trigger beneficial alterations in adipose tissue to improve muscle activity, it's a thermogenic adipomyokine made when the precursor plasma m -Abstract Truncated-
endocrinology & metabolism